Biocryst Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Biocryst Pharmaceuticals Inc
TickerBCRX
CIK #0000882796
CUSIP09058V103
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address2190 Parkway Lake Dr, Birmingham, AL 35244
Source [EDGAR]
CIK Filing 2011 - 2025
[0000882796] 10-K
[0000882796] 10-Q
[0000882796] 3
[0000882796] 4
[0000882796] 8-K
[0000882796] SC 13D
[0000882796] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Avoro Capital Advisors LLC Biocryst Pharmaceuticals Inc [2024-02-14] 6.4
State Street Corp Biocryst Pharmaceuticals Inc [2021-02-05] 6.26
Sarissa Capital Management LP Biocryst Pharmaceuticals Inc [2021-01-25] 5.0
Citadel Advisors LLC Biocryst Pharmaceuticals Inc [2020-06-10] 4.8
Adage Capital Partners GP LLC Biocryst Pharmaceuticals Inc [2020-04-17] 1.62
Point72 Asset Management LP Biocryst Pharmaceuticals Inc [2019-11-19] 6.0
Integrated Core Strategies US LLC Biocryst Pharmaceuticals Inc [2019-05-29] 5.6
Venrock Healthcare Capital Partners II LP Biocryst Pharmaceuticals Inc [2019-02-14] 5.8
Great Point Partners LLC Biocryst Pharmaceuticals Inc [2019-01-11] 6.95
RA Capital Management LLC Biocryst Pharmaceuticals Inc [2018-04-02] 7.1
Great Point Partners LLC Biocryst Pharmaceuticals Inc [2018-02-16] 7.6
RA Capital Management LLC Biocryst Pharmaceuticals Inc [2018-02-14] 7.1
Janus Henderson Group PLC Biocryst Pharmaceuticals Inc [2018-02-12] 6.8
Vanguard Group Inc Biocryst Pharmaceuticals Inc [2018-02-08] 5.87
Flynn James E Biocryst Pharmaceuticals Inc [2017-06-05] 6.81
D E Shaw & Co LP Biocryst Pharmaceuticals Inc [2017-03-06] 5.0
D E Shaw & Co LP Biocryst Pharmaceuticals Inc [2017-01-09] 5.0
RTW Investments LLC Biocryst Pharmaceuticals Inc [2016-08-26] 5.02
D E Shaw & Co LP Biocryst Pharmaceuticals Inc [2016-08-22] 5.1
Baker Bros Advisors LP Biocryst Pharmaceuticals Inc [2016-08-17] 14.95
Flynn James E Biocryst Pharmaceuticals Inc [2016-08-12] 6.64
Venrock Healthcare Capital Partners LP Biocryst Pharmaceuticals Inc [2016-03-28] 7.1
D E Shaw & Co LP Biocryst Pharmaceuticals Inc [2016-03-14] 5.1
Baker Bros Advisors LP Biocryst Pharmaceuticals Inc [2015-11-06] 19.5
BlackRock Inc Biocryst Pharmaceuticals Inc [2015-02-02] 7.6
Baker Julian Biocryst Pharmaceuticals Inc [2014-02-25] 11.3
Wellington Management Co LLP Biocryst Pharmaceuticals Inc [2014-02-14] 8.11
FMR LLC Biocryst Pharmaceuticals Inc [2014-02-10] 0.0
RA Capital Management LLC Biocryst Pharmaceuticals Inc [2013-08-09] 0.9
RTW Investments LLC Biocryst Pharmaceuticals Inc [2013-08-02] 5.1
BlackRock Inc Biocryst Pharmaceuticals Inc [2013-01-30] 6.16
RA Capital Management LLC Biocryst Pharmaceuticals Inc [2012-03-16] 6.5
Form 3/4/5 Filer 2011 - 2025
Heggie Theresa
Biocryst Pharmaceuticals Inc
Ghias Babar
McKee Amy E
Galson Steven K
Frank Steven
Sanders Machelle
Milano Vincent
Levin Alan G
Hutson Nancy J
Thackray Helen M.
Stonehouse Jon P
Barnes Alane P
Doyle Anthony
Gayer Charles K
Abercrombie George B
Aselage Steve
Lee Kenneth B Jr
Ingram Robert Alexander
Jones Michael L
Babu Yarlagadda S
Sheridan William P
Sniecinski Megan
Staab Thomas R II
Powell Lynne
Erck Stanley C
Cohen Fred E
Patel Sanj K
Baker Bros Advisors LP
Baker Felix
Baker Bros. Advisors (GP) LLC
Baker Julian
Sanders Charles A
Jensen Peder
Baker Bros. Investments II, L.P.
Baker/Tisch Investments, LP
667 LP
Baker Bros. Investments, L.P.
Baker Brothers Life Sciences LP
14159 LP
Higgins John L
Horovitz ZOLA P
Lowrey Robert S
McCullough David
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock, Inc. [2025-06-30] SOLE 20,482,553 21,425,849
Vanguard Group Inc [2025-06-30] SOLE 0 20,040,273
State Street Corp [2025-06-30] DFND 7,931,722 8,505,392
Kynam Capital Management LP [2025-06-30] SOLE 8,463,742 8,463,742
UBS Group AG [2025-06-30] DFND 5,617,177 5,622,651
Morgan Stanley [2025-06-30] DFND 5,145,016 5,329,679
Geode Capital Management LLC [2025-06-30] DFND 5,054,610 5,054,610
Alkeon Capital Management LLC [2025-06-30] SOLE 4,762,021 4,762,021
Deerfield Management Company LP [2025-06-30] DFND 4,692,000 4,692,000
Avoro Capital Advisors LLC [2025-06-30] SOLE 4,500,000 4,500,000
D. E. Shaw & Co., Inc. [2025-06-30] DFND 4,321,377 4,389,477
Two Sigma Investments LP [2025-06-30] SOLE 4,288,223 4,288,223
Arrowstreet Capital Limited Partnership [2025-06-30] DFND 4,278,555 4,278,555
Two Sigma Advisers LP [2025-06-30] SOLE 4,079,912 4,228,412
Assenagon Asset Management S.A. [2025-06-30] SOLE 3,620,637 3,620,637
Nuveen, LLC [2025-06-30] DFND 3,460,473 3,534,454
Goldman Sachs Group Inc [2025-06-30] DFND 3,518,614 3,523,917
Bank of America Corp /DE/ [2025-06-30] DFND 140,698 2,841,155
Fisher Asset Management LLC [2025-06-30] DFND 1,492,319 2,782,489
Citadel Advisors LLC [2025-06-30] DFND 2,718,632 2,718,632
Renaissance Technologies LLC [2025-06-30] SOLE 2,526,734 2,526,734
Voloridge Investment Management LLC [2025-06-30] SOLE 2,474,075 2,474,075
Qube Research & Technologies Ltd [2025-06-30] SOLE 2,373,489 2,373,489
Walleye Capital LLC [2025-06-30] SOLE 2,311,928 2,311,928
Rice Hall James & Associates LLC [2025-06-30] SOLE 1,640,999 2,060,280
Millennium Management LLC [2025-06-30] SOLE 1,906,667 2,006,667
Charles Schwab Investment Management Inc [2025-06-30] SOLE 1,969,875 1,969,875
Northern Trust Corp [2025-06-30] DFND 1,880,276 1,881,333
Jupiter Asset Management Ltd [2025-06-30] SOLE 1,855,863 1,855,863
Stifel Financial Corp [2025-06-30] DFND 1,822,976 1,823,288
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com